|
"tsou hh"的相关文件
显示项目 31-55 / 109 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2019-04 |
A post-hoc study of D-Amino acid Oxidase in blood as an indicator of Post-stroke Dementia
|
Chen, YC;Chou, WH;Tsou, HH;Fang, CP;Liu, TH;Tsao, HH;Hsu, WC;Weng, YC;Wang, Y;Liu, YL |
| 國家衛生研究院 |
2019-01-24 |
Prediction of annual dengue incidence by hydro-climatic extremes for southern Taiwan
|
Yuan, HY;Wen, TH;Kung, YH;Tsou, HH;Chen, CH;Chen, LW;Lin, PS |
| 國家衛生研究院 |
2019-01-12 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
|
Yen, CJ;Tsou, HH;Hsieh, CY;Chu, CY;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY;Chang, KY |
| 國家衛生研究院 |
2018-11-29 |
Genetic inhibition of PKCepsilon attenuates neurodegeneration after global cerebral ischemia in male mice
|
Kumar, V;Weng, YC;Wu, YC;Huang, YT;Liu, TH;Kristian, T;Liu, YL;Tsou, HH;Chou, WH |
| 國家衛生研究院 |
2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, LT;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Yen, CJ;Chen, MH;Tsou, HH |
| 國家衛生研究院 |
2018-08-21 |
Design and data analysis of multiregional clinical trials (MRCTs)—Theory and practice
|
Chen, CT;Tsou, HH;Liu, JT;Hsiao, CF;Chen, F;Li, G;Lan, KKG |
| 國家衛生研究院 |
2018-07-27 |
GRK5 is associated with the regulation of methadone dosage in heroin dependence
|
Wang, SC;Chung, RH;Kuo, HW;Liu, TH;Fang, CP;Liu, SC;Liu, CC;Tsou, HH;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2018-03-15 |
Quantification of HBV core antibodies may help predict HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Yuan, Q;Xia, N;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C; Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2018-02-01 |
Inflammatory chemokine eotaxin-1 is correlated with age in heroin dependent patients under methadone maintenance therapy
|
Kuo, HW;Liu, TH;Tsou, HH;Hsu, YT;Wang, SC;Fang, CP;Liu, CC;Chen, ACH;Liu, YL |
| 國家衛生研究院 |
2017-11-16 |
Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine
|
Liu, TH;Chung, RH;Wang, SC;Fang, CP;Tsou, HH;Shih, CL;Kuo, HW;Wang, Y;Liu, YL |
| 國家衛生研究院 |
2017-11 |
Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration
|
Chen, YR;Chou, HC;Yang, CH;Chen, HY;Liu, YW;Lin, TY;Yeh, CL;Chao, WT;Tsou, HH;Chuang, HC;Tan, TH |
| 國家衛生研究院 |
2017-09 |
A tolerance interval approach to assessing the biosimilarity of follow-on biologics
|
Chen, CT;Tsou, HH;Hsiao, CF;Lai, YH;Chang, WJ;Liu, JT |
| 國家衛生研究院 |
2017-03-30 |
Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome
|
Kuo, HW;Shih, CL;Tsung, JH;Liu, SW;Chu, SK;Yang, HC;Tsou, HH;Wang, ZH;Chen, AC;Liu, YL |
| 國家衛生研究院 |
2017-02 |
Integrated care for geriatric frailty and sarcopenia: A randomized control trial
|
Chan, DCD;Tsou, HH;Chang, CB;Yang, RS;Tsauo, JY;Chen, CY;Hsiao, CF;Hsu, YT;Chen, CH;Chang, SF;Hsiung, CA;Kuo, KN |
| 國家衛生研究院 |
2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2017 |
Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C;Group, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2016-11-11 |
Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials
|
Liu, JT;Chen, CT;Lan, KKG;Tzeng, CS;Hsiao, CF;Tsou, HH |
| 國家衛生研究院 |
2016-07 |
Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA
|
Wang, WY;Lin, TY;Twu, CW;Tsou, HH;Lin, PJ;Liu, YC;Huang, JW;Hsieh, HY;Lin, JC |
| 國家衛生研究院 |
2016-07 |
GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer
|
Hsu, CP;Chuang, HC;Lee, MC;Tsou, HH;Lee, LW;Li, JP;Tan, TH |
| 國家衛生研究院 |
2016-06 |
Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials
|
Liu, JT;Tsou, HH;Gordon Lan, KK;Chen, CT;Lai, YH;Chang, WJ;Tzeng, CS;Hsiao, CF |
| 國家衛生研究院 |
2016-05-03 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Shen, YY;Chao, Y;Chen, MH;Yeh, TS;Shan, YS;Huang, SF;Chen, LT |
| 國家衛生研究院 |
2016-04-21 |
The discrete random-effects model-assessing benefit and consistency of treatment effect
|
Tsou, HH;Lan, KKG;Liu, JT;Hsiao, CF |
| 國家衛生研究院 |
2015-09-01 |
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients
|
Liu, SW;Liu, YL;Hwang, LL;Wang, SC;Kuo, HW;Wu, SL;Dai, YWE;Liu, SC;Ho, IK;Chen, ACH;Hsiao, CF;Tsou, HH |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-04 |
Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C |
显示项目 31-55 / 109 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
|
